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INTRODUCTION
Spinal anaesthesia or subarachnoid block as it is popularly called is 
one of the regional anaesthetic techniques achieved by blocking the spinal 
nerves in the subarachnoid space, by injecting local anaesthetic agent into 
the sub arachnoid space.1
Sub arachnoid  block is  commonly  used  in  surgeries  of  the  Lower 
abdomen and lower limbs.
Though it is a blind procedure, it is easy  to perform and gives good 
intensity  of  sensory,  motor  &  sympathetic  blockade  of  rapid  onset. 
Depending  upon  the  local  anaesthetic  injected  the  duration  of  blockade 
varies.
Spinal  anaesthesia2 has  the  advantage  over  General  anaesthesia  in 
preventing  the  sympathetic  response  from  laryngoscopy  and  intubation. 
However it is not devoid of fatal complications of which hypotension and 
bradycadia  are  the  hemodynamic  complications  resuting  in  significant 
morbidity and mortality.
Many  factors  have  been  found  to  result  in  hypotension  in 
midthoracic level subarachnoid block1 of which important ones are 
(1) sympathetic  blockade  leading  to  decrease  in  systemic  vascular 
resistance thereby causing hypotension.
(2) Increased  venous  capacitance  reducing  the  venous  return  causing 
decreased cardiac output leading to hypotension.
(3) Bradycardia  again  by  reducing  the  cardiac  output  results  in 
hypotension.
Hence  it  is  of  paramount importance  to  treat  hypotension and its 
complications  but  prevention  is  better  than  allowing  it  to  happen  and 
treating it .Various methods have been tried to prevent hypotension.1
1. parenteral administration of vasopressors 
2. preloading with crystalloids and colloids and
3.using compression stocking or pneumatic devices in the lower limbs to 
improve venous return.
Parenteral  administration  of  ephedrine3 for  prevention  of 
hypotension has been tried in various clinical studies but not much studies 
have been done to know the efficacy of prophylactic oral administration of 
ephedrine.
Therefore  a  prospective  randomized  clinical  study  is  done  to 
determine  the  efficacy  of  prophylactic  oral  ephedrine  in  reducing   the 
incidence  of  hypotension  following  subarachnoid  block  in  patients 
undergoing elective lower abdominal and scrotal surgeries.
AIM OF THE STUDY
Aim of this study is to determine the efficacy of prophylactic oral 
ephedrine  administered  before  subarachnoid  block  in  minimising   the 
incidence of spinal anaesthesia induced hypotension in patients undergoing 
elective lower abdominal   and scrotal surgeries.
HISTORY OF SPINAL ANAESTHESIA1
Cerebrospinal fluid was discovered by Domenico  Cotugno in 1764. 
Its circulation was described by F. Magendie in 1825. 
The first spinal  analgesia was introduced to this world in 1885 by 
Leonard  corning, a New York neurologist when he accidentally pierced the 
dura while experimenting cocaine on spinal nerves of a dog. Later in 1891 
Heinrich  Irenaeus  Quincke  standardized  lumbar   puncture  as  a  simple 
clinical procedure.  
The first planned spinal analgesia for surgery in man was  performed 
by august Bier on 16th  August 1898.  He injected 3ml of  0.5%  cocaine 
solution into a 34 year old man.. In 1903 adrenaline was  used to increase 
the duration and reduce the toxicity of spinal analgesia.  
Ephedrine was introduced in 1923 by Chen and Schmidt.  It was used 
for maintaining blood pressure in spinal analgesia in 1927 by Ocherblad, 
Dillon, Rudolf and Graham.  In Earlier years the special attention was  with 
the advancement of spinal   anaesthesia. The reasons being:   
(i) The end point of CSF return was well defined.
(ii) Spinal  anaesthesia  produced  superb  skeletal  muscle  relaxation 
facilitating surgical exposure at the time when muscle relaxants 
had not been introduced.
These  advantages  of  spinal  anaesthesia  historically  created  many 
enthusiastic  clinicians.  Newer  drugs  like  stovaine,  procaine,  spinocaine, 
duracaine  were  being  discovered.  Spinal  anaesthesia  was  being  used  for 
surgeries in abdomen, head, neck and thorax.
Morton  promoted  high  spinal  anaesthesia  for  surgical  procedures 
carried out on the head and neck.
Koster used  total  spinal  blockade  for  thoracic  and  intracranial 
procedures.  Spinal  anaesthesia was not limited to surgical  conditions but 
was used for  treatment of  medical  conditions  (eg.  Pulmonary edema)  by 
taking advantage of its venodilatory effect.
Anaesthesiologists continue to face confusion about balancing the risks 
and benefits of spinal anaesthesia.
One impediment to the effective use of neuraxial block is the predictable 
decrease in arterial blood pressure and heart rate through the accompanying 
sympathetic  blockade  with  its  attendant  vasodilatation  and  blockade  of 
cardioaccelerator fibres.
ANATOMY  RELATED  TO  THE  SUBARACHOID 
BLOCK4
 The vertebral column consists of  7 cervical, 12 thoracic, 5 lumbar, 5 
sacral and 4 to 5 coccygeal vertebrae.   
The Vertebral column has two primary curves,  thoracic and sacral 
which are concave anteriorly, two secondary curves namely cervical  and 
lumbar. The intervertebral disc makes up for one-quarter of the length of 
vertebral column. 
The Vertebral canal is bounded in front by  bodies of the vertebrae 
and   intervetebral disc, posteriorly by the laminae, ligamenta flava and the 
arch.  
  Contents of the vertebral canal are ,
 (i)  roots of spinal nerves, 
(ii)  spinal  membranes  with  their  enclosed  cord  and  cerebrospinal 
fluid 
(iii)structure like vessels, fat and areolar tissue of epidural space.
The vertebral ligaments binding the canal are: 
(i) Supraspinous ligament.
(ii) Interspinous ligament
(iii) Ligamenta flava
(iv) Posterior longitudinal ligament
(v) Anterior longitudinal ligament
Spinal  cord  is  the  elongated  part  of  the  Central  Nervous  system 
which  occupies  upper  two  –  thirds  of  the  vertebral  canal  and  is 
approximately 45 cms long in adults.
It extends from upper border of atlas to upper border of 2nd lumbar 
vertebra.  Below it  ends  in  conus  medullaris,  from the apex of  which 
filum terminale descends as far as coccyx. In adults the spinal nerve roots 
pass out  obliquely through the intervertebral foramen. The lumbar and 
sacral nerve roots, descend almost vertically to meet their foramina and 
are known as cauda equinae. 
The spinal cord is ensheathed by three membranes from outwards to 
inwards.
Duramater :  The spinal duramater represents only the inner or 
meningeal part, outer part is represented by the periosteum lining the 
vertebral canal. A strong fibrous layer forms a tubular sheath attached 
above to the margins of foramen magnum and ending below at lower 
border of S2 sacral vetebra.
Arachnoid : This  is  a thin transparent sheath closely applied to 
the dura, surrounding the cranial and spinal nerves as far as their point 
of exit from skull and vertebral canal.
Pia Mater: This  is  separated  from  the  arachnoid  by  the 
subarachnoid space filed with cerebrospinal fluid. The piameter closely 
invests the cord and sends septa into its substance. A lateral fibrous band 
called  denticulate  ligament  projects  into  the  subarachnoid  space.  A 
posterior  midline  septum,   has  been  described.  It  ends  as  the  filum 
terminale which pierces the distal end of dural sac and is attached to the 
periosteum of coccyx .
Subdural space is a potential space between dura and the arachnoid. 
Injection of local analgesic into it may cause inadequate or abnormally 
high block,.
Subarachnoid  space  lies  between  arachnoid  and  piamater.  The 
contents  of  the  space  are  the  spinal  nerve  roots,  the  denticulate 
ligaments,  a  spongy  reticulum  of  fibres  connecting  the  pia  to  the 
arachnoid, cerebrospinal fluid, the larger vessels and spinal nerves.
Anterior root is efferent and motor. Sympathetic preganglionic axons 
arise from cells in the intermedio lateral horn of the spinal cord from T1 
to L2.Posterior root is larger and has a ganglion and conveys fibres of (i) 
Pain, (ii) Tactile (iii) Thermal (iv)Deep pressure and proprioception (v) 
afferents from the viscera and (vi) Vasodilator fibres.
The anterior and posterior roots with its covering of pia , arachnoid 
and dura crosses extradural space and unite in the intervertebral foramen 
to form the main spinal nerve trunks which soon divide into anterior 
and posterior primary divisions.
BLOOD SUPPLY TO THE SPINAL CORD
 Poster  spinal  arteries,  two  on  each  side,  branch  from  posterior 
inferior cerebellar arteries; it supplies the posterior column of spinal 
cord.
 Anterior spinal Artery, a single vessel, branch from the junction of 
two small branches from each vertebral artery. It supplies lateral and 
anterior columns, about 3/4th of the substance of the spinal cord. It 
receives  communications  from  the  intercostal,  lumbar  and  other 
small arteries. Communicating branches at the level of T10 and T11 
larger than the others and help to supply the enlargements of cord.
Extra  dural  veins :They largely form a plexus, most dense in the 
anterolateral part of the extradural space. They receive blood from the cord 
and the vertebral canal with its contents and communicate with both the 
intracranial  sinuses and the tributaries  of the inferior vena cava and the 
azygos system.
NERVE SUPPLY OF MENINGS
The posterior  aspect  of  the dura  and arachnoid contains  no nerve 
fibres  and  so  no  pain  is  felt  on  dural  puncture.  The  anterior  aspect  is 
supplied by spinovertebral nerves.
PHYSIOLOGY RELATED TO SUBRACHNOID 
BLOCK4
Zone of Differential Block:
Sensory  :  In intradural block sympathetic fibres are blocked 2 to 6 
segments higher than sensory fibres. Sympathetic blockade will be greater 
when more concentrated solutions are used (or) when adrenaline is used.
Motor:   In intra dural blockade, the difference between sensory and 
motor block is slight (two segments). Motor block is two segments below 
sensory block.
Differential action of local anaesthetic on nerve fibre :
All types of nerve fibres are affected by local anaesthetic agent, there 
is a tendency for small, slow conducting fibres to be more rapidly blocked 
than large fast conducting fibres.
In case of medium sized fibres however, these rules do not hold good. 
Myelinated preganglionic beta fibres which have faster conduction time are 
about three times more sensitive to blockade than slower post ganglionic C-
fibres.
The Order of Sensitivity to Blockade seems to be (Collins et al)
a. Preganglionic  sympathetic  fibres  –  Vasomotor  blockade  – 
dilatation  of  cutaneous  blood  vessels  –  increases  cutaneous 
blood flow.
b. Temperature  fibres  –  cold  affected  before  warm  leading  to 
sensation  of  warmth  by  patients  and  finally  temperature 
discrimination is lost.
c. Pin prick fibres
d. Fibres conveying pain greater than pin prick.
e. Touch fibres
f. Deep Pressure fibres
g. Somato motor fibres
h. Fibres conveying vibratory sense and proprioceptive impulses.
During recovery return of activity in the reverse order was assumed. 
Sympathetic fibres are the last to recover from blockade. (Collins et al).
FACTORS CONTROLLING THE LEVEL OF SPINAL ANESTHESIA
1. Effect of Gravity
- Specific gravity of local anaesthetic solution
- Baricity of the Solution 
- Position of the patients
2. Effect of Volume
3. Concentrations of drug 
4. Rate and force of injection
5. Site of injection
6. Pregnancy, large intra abdominal tumours, morbid obesity and 
other  conditions  leading  to  increased  intra  abdominal 
pressures.
7. Pressure of cerebro spinal fluid
8. Age.
FACTORS AFFECTING THE DURATION OF ANAESTHESIA
1. Dose and concentration of drug
2. Presence of vasoconstrictors which delays systemic absorption
CIRCULATORY EFFECTS OF SUBRACHNOID BLOCK
The  preganglionic  sympathetic  fibres  arise  from  the  spinal  cord 
between T1 and L2 and run in the corresponding anterior roots across the 
subarachnoid and epidural spaces. Most of the effects of spinal anaesthesia 
on  cardiovascular  system  is  due  to  the  blockade  of  this  preganglionic 
sympathetic fibres.
Hypotension following subarachnoid blockade is due to
(i) Sympathetic blockade leading to dilation of both resistance and 
capacitance  vessels.  Peripheral  venous  pooling  which  occurs  causes 
reduction  of  venous  return  with  subsequent  fall  in  stroke  volume  and 
cardiac output.
(ii) Blocking of cardiac efferent sympathetic fibres form T1 to T4 
resulting in loss of chronotropic and ionotropic drive to the heart, causing a 
fall in the cardiac output.
(iii) Paralysis  of  sympathetic  nerve  supply  to  the  adrenal  glands 
with consequent catecholamine depletion.
(iv) Blocking  of  muscular  propulsive  forces  on  the  veins  in  the 
lower limbs, decreasing venous return.
Segmental blockade of the sympathetic nerves upto level T5 can be 
compensated in a normovolemic by vasoconstriction in the upper part of 
the body. This compensation occurs with little change in the cardiac output 
and with little more than 5% to 20% fall of the mean arterial pressure. Thus 
it  is  possible  for  a  large  part  of  arteriolar  bed  to  be  dilated  under  the 
influence  of  the  sympathetic  blockade  while  total  peripheral  vascular 
resistance changes little, due to compensatory vasoconstriction elsewhere. If 
the blockade extends beyond T4 and if more of the sympathetic outflow is 
blocked including cardioacceleratory fibres, then it becomes more difficult 
to  compensate  for  these  haemodynamic  changes  and  the  blood  pressure 
falls.  If  the pressure  continues  to  fall  below a  certain critical  level,  it  is 
probably  due  to  an  associated  reduction  of  venous  return  and  cardiac 
output.
The  baro-receptors  in  the  carotid  sinus  and  aortic  arch  normally 
respond to a fall in blood pressure by producing compensatory tachycardia 
(Marey’s Law) through vagal afferent and efferent pathways. Many patients 
under spinal anaesthesia exhibit bradycardia and hypotension and it appears 
that  Bainbridge  Reflex  predominates.  This  reflex  is  mediated  by  the 
receptors in the great veins and right atrium which adjust the heart rate 
according to the venous filling pressures.
PHYSIOLOGY OF CEREBROSPINAL FLUID
CSF was discovered by Domenico Cotuqno and its circulation was 
described  by  F.  Magendie.  CSF  an  ultrafiltrate  of  plasma,  is  a  clear, 
colourless fluid found in the ventricles of the brain.
Total volume of CSF ranges from 120-150ml of which 25-35ml is in 
the spinal subarchnoid space. CSF pressure ranges from 60-80 cm of water. 
It  is  formed  by  either  secretion  or  ultrafiltration  from  choroid  arterial 
plexuses of the lateral, III & IV ventricles.
Composition of CSF:
Protein 15-45 mg%
Glucose 50-80 mg%
Chloride 20-130 meq / lit
Sodium 40-150 meq / lit
Bicarbonate 25-30 meq / lit
Ph 7.4 – 7.6
Characteristics of spinal fluid:
Specific gravity – 1.003 – 1.009
Volume – 130 – 150 ml
Circulation of CSF:
Chroid plexus in the Lateral ventricles           through foramen of 
Manroe  3rd Ventricle          Aqueduct of Sylvius            4th Ventricle 
through foramina of Luschka and Magendie              subarachnoid space.
PHYSIOLOGY OF SPINAL HYPOTENSION
Theories of causation of fall in blood pressure1
1. Reduced cardiac output due to reduction of venous return to heart 
and lack of propulsive force on veins.
2. Dilatation  of  post  arteriolar  capillaries  and  small  venules  due  to 
paralysis of vaso constrictors.
3. Paralysis  of  sympathetic  nerve  supply  to  the  heart  (T1 –  T4). 
Bradycardia may give rise to fall in cardiac output.
4. Paralysis  of  sympathetic  nerve  supply  to  the  adrenal  glands  with 
consequent catecholamine depletion.
5. Absorption of drug into circulation.
6. Ischaemia and hypoxia of vital centers
7. Pre  existing  hypovolemia  may  give  rise  to  severe  fall  in  blood 
pressure if  central neuraxial blockade is employed.
8. Compression of great vessels within the abdomen by the pregnant 
uterus or abdominal tumours or abdominal packs may cause severe 
hypotension in the presence of central neuraxial blockade.
Block not extending above T4 is  not always associated with fall in 
blood pressure in fit young adults.
Blood pressure  fall   is  usually  seen in the first  20 minutes  after  a 
block. Corrective measures may be considered if arterial pressure falls more 
than 20% of baseline value.
Treatment of spinal hypotension
1. Rapid infusion of I.V. Fludis
2. O2 inhalation
3. Foot end elevation
4. Injection of pressor drug – ephedrine or mephenteramine.
5. Injection of atropine if there is bradycardia.
Preventive measures to reduce the incidence and severity of maternal 
hypotension associated with spinal anaesthesia.
1. Patient  positioning  to  avoid  aortocaval  compression  and 
promote cardiac preload.
2. Prehydration to expand blood volume, increase cardiac preload 
and thereby avoid the sudden decrease in cardiac preload.
3. Prophyactic or immediate use of appropriate vasopressors.
PHARMACOLOGY OF BUPIVACAINE 5
Bupivacaine  is an amide local anaesthetic introduced in 
1963.
Structure                                           
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It is a hydrochloride salt of 1 butyl 2’6’ pipecoloxylide 
and is  presented as  racemic mixture.It  is  a  chiral  drug as  it  possesses  an 
asymmetric carbon atom.
It consist of lipophilic portion and hydrophilic portion separated by a 
connecting hydrocarbon chain. Hydrophilic portion is a tertiary amine and 
the lipophilic portion is  an unsaturated aromatic ring such as  paraamino 
benzoic acid.
The lipophilic portion is essential for anaesthetic activity .
Addition of butyl group to the piperidine nitrogen of mepivacaine 
results in bupivacaine which is 35 times more lipid soluble and has potency 
and duration of action 3 to 4 times that of mepivacaine .
It  is  four  times  potent  as  lidocaine  .It  is  slower  in  onset  but  has 
significantly longer duration of action.
Mechanism of action (Butterworth and strichasty 1990)
It prevents the transmission of nerve impulses (conduction blockade) 
by inhibiting passage of sodium ions through ion selective sodium channels 
in nerve membranes. This slows the rate of depolarization so that threshold 
potential is not reached and this action potential is not propagated.
Pharmacokinetics
It is rapidly absorbed from the site of injection. It has a long elimation 
half life (2.7hr) accompanied by low plasma clearance (0.58 l/min). These 
tend to increase the risk of systemic toxicity. It is 95% protein bound mainly 
α1 acid glycoprotein.
Most of the drug is metabolised in the liver  by microsomal enzymes. 
Due to the slower metabolic rate this drug increases the risk of systemic 
toxicity and cumulative drug effects are more likely.
Poor  water  solubility  of  this  drug  makes  the  renal  elimination  of 
unchanged  fraction to less than 5%.Only little amount crosses the placenta.
Pharmacodynamics 
Onset of action is slow but it has longer duration of action. Increasing 
the concentration of thisdrug will increase the degree of motor block.
Indications
Local anaesthesia
Any nerve block
Spinal Anaesthesia
Epidural Anaesthesia
Dosage
It is used in concentrations of 0.5% to 0.75 for spinal anaesthesia
Toxicity 
Toxicity of this drug is due to the plasma concentration exceeding 1.5 
to 2 μg / ml and is most likely due to the inadvertent intravenous injection.
Neurotoxicity is the most common side effect of this drug which will 
result in seizures. Mild side effects like restlessness , vertigo, slurred speech, 
muscle twitching will be followed by seizures. Later on CNS depression may 
follow which will produce hypoxia and apnea.
Cardiotoxicty is more in bupivacaine compared to equipotent dose of 
lignocaine. It may produce profound hypotension, dysrrhythmias and heart 
block. Dissociation of highly lipid souble bupivacaine from sodium channels 
receptors is slow accounting for persitent depression of myocardium.
PHARMACOLOGY OF EPHEDRINE 5,6
History 
It is an alkaloid obtained from Chinese herb Ma Huang. It was tasted 
by the Emperor shen Nung who placed it in the medium class. According to 
Pentsao Kang Ma Chinese dispensary written in 1596 by shih cheng le Ma 
Huang  is  of  value  as  circulatory  stimulant,  diaphoretic,  antipyretic, 
antitussive and it is an ingredient of many preparations. 
Chen and schmidt introduced ephedrine into the western medicine 
in  1924  in  the  belief  that  actions  of  the  drug  were  essentially 
sympathomimetic    Chemical Name
(1R, 2S) 2 methylamino – 1, Phenylpropanolol 
Chemical Formula
C10 H15 NO
Structure
CH – CHNHCH3
                                 OH   CH3
  
Mechanism of action 
Ephedrine  has  direct  effect  on  stimulation  of  alpha  and  beta 
adrenergic receptors and indirect effect by liberating norepinephrine from 
the stores of neurons.
Pharmacologic properties
In cardiovascular system it produces vasoconstriction, increases cardiac 
contractility and increases heart rate. All these result in increased cardiac 
output and increased arterial pressure.
 Stimulation of  B2 adrenergic  receptors  at  bronchial  smooth muscle 
produces  bronchodilation  and  at  urinary  system  it  produces  sphincter 
contraction and relaxation of vesical wall which causes urinary  retention.
It has very little effect on uterine activity.
In CNS it produces stimulation.
In GI system it reduces intestinal tone and motility.
It dilates the pupil but does not affect light reflexes.
Pharmaco kinetics 
Bioavailability  after  oral  route  of  absorption  is  85% producing peak 
effect in 1 to 2 hrs. With topical administration absorption is 64%.
Onset of action
It has immediate effect in intravenous form, by intramuscular route 
onset is 10 to 20 minutes and in oral & subcutaneous route it has gradual 
onset.(20 to 30 minutes)
Duration of action
Vasopressor  and  cardiac  effects  are  observed  upto  60  min  if 
administered by intramuscular route. By oral route its effect may last upto 5 
hrs and by intranasal route decongestant effect last for 3 to 6 hrs.
Metabolism 
It is metabolized by oxidative deamination, desmethylation, aromatic 
hydroxylation  and  conjugation.  It  is  resistant  to  the  action  of 
MAO(MonoAmine Oxidases)  and COMT.(Catechol-o-Methyl Transferases)
Excretion
By renal  route depending on urinary PH. Elimination is  enhanced 
and halflife is shorter in acidic urine.
Preparations and routes of administration 
15 mg Tablets
30mg / ml Ampoules
It can be administered by oral, subcutaneous, intramuscular or 
intravenous routes.
Therapeutic uses
1. It is used to prevent or treat hypotension induced by spinal or 
epidural anaesthesia.
2. As a bronchodilator 
3. As nasal decongestant 
4. to treat post operative nausea & vomiting 
5. To treat urinary incontinence 
6. Treatment of nocturnal enuresis    
7. Treatment of obesity
8. As mydriatic 
Adverse effects
     CVS  – Palpitation, Tachycardia, Hypertension
CNS  –  Nervousness,  Fear,  Anxiety,  Hallucinations,  Psychosis  and 
Depression with chronic use.
Genitourinary system: Urinary retention
Skin  - Hypersensitivity, Rashes
In Fetus- Hyperactivity, Irritabilty & Fetal Tachycardia.
Miscellaneous
Dry mouth
Tremor
Tachyphylaxis  with repeated use 
Precautions to be taken in cases of
Prostatic Hypertrophy
Arterial Hypertension 
Coronary artery disease
Diabetes mellitus 
Hyperthyroidism 
Renal impairment / closed angle glaucoma.
Drug interaction
Administration of ephedrine may cause hypertensive crisis in patients 
receiving  MAOI.  It  may  cause  arrythmias  in  patients  receiving  ergot 
alkaloids or oxytocin .
REVIEW OF LITERATURE
Hypotension  is  the  most  important  complication  following  spinal 
anaesthesia various methods have been studied to prevent hypotension.
Lot of literature supporting parenteral administration of prophylactic 
ephedrine  are  available  but,  only few literatures  supporting prophylactic 
oral ephedrine are available.
Though  many  pressor  agents  are  available  to  prevent  &  treat 
hypotension,  ephedrine  remains  the  standard  drug  for  spinal  induced 
hypotension.
Kafle,  Malla  and  Lekhak 7 in  1994 studied  the  efficacy  of  oral 
ephedrine for  prevention of  spinal  induced hypotension in two hundred 
women of ASA class I and II undergoing lower abdominal surgeries. The 
patients were divided into two groups randomly (n = 100 each).
All  patients  were  given  routine  oral  premedication consisting  of 
diazepam 10mg and ranitidne 150mg at  bed  time and at  90  min before 
surgery. In addition Group I patients received ephedrine 30mg orally 30min 
before subarachnoid block was administered. Group II received only routine 
premedication.  After  starting  IV  line  and  preloading  with  10  ml/kg 
crystalloid  ,  patients  were  given  0.5%  heavy  bupivacaine  3.2  to  3.6ml 
depending on body 
weight intrathecally. Patients with decreases in blood pressure of more than 
20% of baseline systolic value were given ephedrine IV in increments in 
addition to crystalloids.  Despite a similar level of block (T3 – T4)  and IV 
fluids, the total dose of ephedrine supplement in Group I was 4.3 +/- 4.8 mg 
compared with 11.6 + % 9.4 mg in Group II (P<0.01) Also 55 patients in 
Group I, required intraoperative ionotrope  supplement compared with 83 
in Group II (P < .0.01).
They concluded that oral ephedrine premedication is a simple and 
effective  way  of  reducing  the  incidence  of  hypotension  in  patients 
undergoing  lower  abdominal surgeries under SAB.
Fusun  eroglu  8 et al  studied prophylactic effects  of systemic oral 
ephedrine in spinal Anaesthesia induced hypotension during TURP, at dept 
of Anesthesiology. Suleiman Demirel university Ispaita, Tulkey.
They studied sixty ASA Grade II and II patients scheduled for spinal 
Anesthesia.
They were randomly divided into two groups. Patients in Group I (n 
=  30)  received  oral  ephedrine 50mg in addition  to  premedication whilst 
those in Group II (n = 30) received only premedicaiton 30min before spinal 
anaesthesia. Hypotension was defined as SAP < 20% of baseline value and 
was 
treated with 3mg ephedrine and bradycardia was corrected with atropine 
0.5mg given as an iv bolus. 
They  found  that  SAP  values  were  significantly  lower  in  group  II 
during spinal. Post spinal & intraoperative periods, (P<0.0001). 15 patients 
received  ephedrine  in  Group  II  and  seven  in  Group  I  .Supplemental 
ephedrine was used at doses of 3.42 + 0.97 mg in Group I and 8.86 + 1.20mg 
in group II. The incidence of hypotension was halved in group I compared 
to  Group II (23.33 % Vs 50%, p < 0.003)  Six patients received atropine in 
Group II  because  of  severe  bradycardia.  Mean HR values  were lower in 
Group II than Group I during study period.
They concluded that prophylactic oral   ephedrine at  50mg dose is 
effective for measuring spinal induced hypotension during TURP.
Subbiah et al studied at Madurai Medical College 50 patients of ASA 
I  undergoing  elective  LSCS  to  evaluate  the  efficacy  of  prophylactic  oral 
ephedrine  30mg to  prevent  spinal  hypotension.  Study was  conducted  in 
double  blind  randomized  controlled  trial  and  they  found  out   that 
prophylactic  administration  of  oral  ephedrine  is  associated  with  lower 
incidence  of  hypotension  after  SAB in  LSCS  when  compared  to  control 
group and has no side effects.
 PF Kotur et al have done a randomized clinical trial of comparison 
of  prophylactic  oral  ephedrine  and control  in  reducing  the  incidence  of 
hypotension after  SAB at  JN Medical  college.  Belgaum, Karnataka.  They 
studied 100 patients of both sexes between the age group of 20 – 60 yrs 
belonging to ASA I & II scheduled for elective lower abdominal surgeries 
under SAB and found that prophylactic administration of oral Ephedrine 
was associated with lower incidence of hypotension after SAB with  (22% 
Vs 76%) when compared to control group.
T.  Kushimo et  al  at  Nigeria  studied  sixty  patients  for  elective 
caesarian  section  randomly  allocating  into  two  groups.  One  group  was 
infused with 1L of  0.9% saline before spinal block and group 2 was infused 
with ephedrine 30mg in 1 L of  0.9% saline after spinal block and concluded 
that  prophylactic  ephedrine  given  by  standard  infusion  set  was  more 
effective than any standard infusion set was more effective than crystalloid 
prehydrasion  in  prevention  of  Hypotension  during  spinal  for  elective 
caesarian section.
Loughery JP.  Walsh f,  Gardiner  J  9 at Ireland did a randomized 
control study in 68 patients undergoing SAB the efficacy of prophylactic 
intravenous ephedrine in prevention of spinal induced hypotension with  2 
ml  of 0.9% 
saline in one group , 6mg ephedrine IV in 2nd Group and 12mg ephedrine in 
3rd group and concluded that prophylactic bolus of ephedrine 12mg IV given 
at the time of intrathecal   block leads to lower incidence of hypotension 
following spinal Anesthesia for elective LSCS patients.
Ayorinde   BT  10 et al UK studied 108 patients undergoing elective 
LSCS under  SAB,  assigned to  four  groups  in  a  randomized double  blind 
placebo controlled study, Group I received preemptive phenyl ephrine 4mg 
im , group 2 received phenylephrin 2mg im and group 3 received ephedrine 
45mg  im  while  control  group  received  im  injection  of  saline,  all  given 
immediately  after  spinal  anesthesia.   They  found  out  that  incidence  of 
hypotension was 33% in phenylephrine 4mg group, compared with 70% in 
control  group  &  phenylephrine  2mg  group  and  48%  in  the  ephedrine 
group .
Simon L 11 et al studied 108 women undergoing elective LSCS under 
spinal anesthesia by giving 10, 15, 20mg ephedrine IV bolus 2 minutes after 
intrathecal injection as prophylaxis and concluded that single bolus of IV 
ephedrine  with  doses  of  either  15  or  20mg  decreased  significantly  the 
incidence of maternal hypotension as compared to a single 10mg bolus of 
ephedrine.
Gajaraj  NM  12 et al compared ephedrine infusion with crystalloid 
administration for prevention of hypotension during spinal anesthesia in 54 
ASA  I  patients  undergoing  postpartum  tubal     ligation  under  spinal 
anesthesia.  One  group  received  15  ml/kg  of  crystalloid  and  other  group 
received  ephedrine  infusion  and  concluded  that  prophylactic  ephedrine 
influsion is effective for minimising  and managing hypotension associated 
with  spinal  anaesthesia  and  also  found  that  reactive  hypertension  or 
tachycardia did not occur in the ephedrine group.
Rout  CC  13 et al reevaluated the role of crystalloid preload in the 
prevention of hypotension associated with the spinal anesthesia for elective 
caesarian section,  in 140 patients of two groups,  one  with 20 ml/kg  of 
crystalloid  administration  and  another  group  with  out  crystalloid 
administration and found that crystalloid administration was not effective 
in preventing hypotension.   
Hemmingsen C  14 et al studied 48 patients undergoing LSCS under 
spinal anaesthesia to know the efficacy of prophylactic im ephedrine in two 
different  doses  of  12.5mg  and  37.5mg  and  found  that  prophylactic 
ephedrine is desirable in spinal anaesthesia .
Sternlo  JE  15 et al investigated the efficaly of im ephedrine in 98 
elderly patients  undergoing hip arthroplasty under spinal anaesthesia.  50 
patients  were  given  0.6  mg  /  kg  of  ephedrine  deep  in  the  paravertable 
muscles immediately after spinal and 48 patients received equal volume of 
saline  and  concluded  that  prophylactic  im  ephedrine  is  a  simple  and 
effective means of reducing the incidence of hypotensive episodes. 
Jackson. R 16 et al compared the protective effect of 1000ml preload 
with  200ml  preload  of  crystalloid  solution  administrated  during  10  min 
before  spinal  anaesthesia  in  60 women undergoing LSCS and found that 
crystalloid preloading is not effective.
Webb AA 17 et al assessed the efficacy of prophylactic im ephedrine 
to  prevent  hypotension  in  spinal  Anaesthesia  for  caesarian  section.  40 
patients divided into two groups of 20 each. One group received 37.5mg im 
ephedrine and other group received placebo and they found that incidence 
of hypotension is less in ephedrine group.
Di  Roio  C  18 et al studied 20 patients aged 60 yrs or more of ASA 
class II or III scheduled for surgical  correction of Fractured neck of femur 
under  SAB.  One  group  (n=10)  received  ephedrine  30mg  intramusculary 
immediately  after  SAB.  The  other  group  received  1ml  of  saline 
intramuscularly. They found that prophylactic intramuscular ephedrine is 
effective to prevent hypotension associated with SAB.
Kee WD  19 et al studied 80 women undergoing LSCS divided into 4 
groups  of 20 each receiving saline, ephedrine 10mg, 20mg, or 30mg IV, 1 
minute after intrathecal injection and concluded that ephedrine 30mg dose 
was effective in reducing incidence of hypotension.
Vercauteren   MP  20  et al studied 50 patients undergoing spinal 
anaesthesia and compared the efficacy of prophylactic ephedrine 5mg im Vs 
saline  IV  to  prevent  spinal  hypotension  and  found  that  prophylactic 
ephedrine  decreases  the  occurrence  and   reduces  the  severity  of 
hypotension.
Butterworth et  al  found that a  mixed adrenergic  agonist  such as 
ephedrine more ideally corrected the non cardiac  circulatory sequelae  of 
total  spinal  anaesthesia  in  dogs  than  did  either  a  pure  alpha 
(Phenylephrine ) or a pure beta adrenergic agonist (isoproterenol)   
Goertz et al investigated the effect of ephedrine on left ventricular 
function  in  patients  without  cardiovascular  disease  under  high  thoracic 
epidural  analgesia  combined  with  General  Anaesthesia.  Ephedrine 
improved left ventricular contractility without causing relevant changes of 
left ventricular after load. 
MATERIALS & METHODS
After  getting  ethical  committee  approval  and  informed  consent  a 
randomised  clinical  study  was  conducted  in  100  ASA  class  I  men 
undergoing  elective  lower  abdominal  and  scrotal  surgeries  under  spinal 
anaesthesia  to  evaluate  the  efficacy  of  prophylactic  oral  ephedrine  in 
prevention of spinal induced hypotension.
This study was carried out in Govt. Stanley medical  College, Chennai 
during the period of Oct 2005 to Oct 2006.
Inclusion criteria were
1. ASA Class I patients
2. Age between 25-55 Yrs
3. Patients coming  for  lower abdominal and scrotal surgeries.
Exclusion criteria were
1. obesity
2. Height less than 155cm
3. Diabetes
4. hypertension
5. Ischaemic heart disease
6. Chronic renal failure
7. Anaemia
8. Bleeding disorders 
9. Epilepsy 
Preoperative preparation
Thorough  preoperative  assessment  with  detailed  medical  history, 
physical examination and investigations were carried out. Each patient was 
explained  about  the  procedure  and  type  of  anaesthesia  and  informed 
consent was obtained.
All patients were advised to fast 6 hrs for solids and 4 hrs for liquids 
before  surgery  and  no  intravenous  fluids  were  administered  until  the 
patients  arrived   in  the  premedication  room.  All  the  patients  were 
premedicated with 10mg of Tab.diazepam and 150mg of Tab. Ranitidine at 
bedtime on the  previous night of surgery. No premedication was given in 
the morning of surgery.
Investigations
Hb%,PCV
Total Count
Differential count
Blood sugar
Blood Urea
Serum creatinine
Bleeding time
Clotting time
Platelet count
Urine analysis for Albumin sugar and deposits
ECG
Chest X – Ray
And relevant investigations if needed .
These 100 patients  were randomly allocated into two groups of 50 each. 
Patients in Group E (ephedrine group) received 30mg of Tab.  Ephedrine 
with sips of water 30min prior to spinal anaesthesia and patients in group C 
(control group)  received no tablets. 
Average of three readings of blood pressure at 5 minutes  intervals 
prior to administration of Tab ephedrine & iv fluids was taken as baseline 
blood pressure. Similarly baseline heart rate and SPO2 were measured.
Patients  were  shifted  to  operation  theatre  20  minutes  prior  to 
administration  of  spinal  anaesthesia  and  were  connected  to  multipara 
monitor and NIBP, ECG, SPO2 were monitored continuously. An IV Access 
using  18  g  iv  cannula  established   over  the  left  forearm  under  aseptic 
precautions.  Patients  in  both  groups  were  preloaded  with  10  ml/kg  of 
Ringer lactate over a period of 15 minutes.
Anaesthesia 
At the end of 15min(ie after preloading ) patient was placed in right 
lateral postion. Under aseptic precautions and draping L3 L4 inter vertebral 
space was  identified  and sub arachnoid block  was  performed with 23G 
quinke  Babcock  spinal  needle  after  ensuring  free  flow of  cerebro  spinal 
fluid. Depending upon the weight and height of the patient 3.2 to 3.5 ml of 
0.5%  hyperbaric  Bupivacaine  was  injected  slowly  over  a  period  of  20 
seconds.  Immediately  after  injection  of  the  drug  ,patient  was  turned  to 
supine position.
Level of sensory block was assessed using pinprick sensation. Once 
the level reached T6 –T8, the level of block was optimized by giving 100 
head tilt   position  or  keeping  pillow under the  chest  and head till   the 
fixation of drug i.e 20 – 30 minutes. Crystalloid at the rate of 10ml / kg / hr 
was used for maintenance during the intra operative period.
All  patients  were sedated with 1.5mg of  midazolam 5min prior  to 
skin incision 
Monitoring            
All the patients were monitored throughout the procedure. Systolic 
Blood Pressure, Diastolic blood pressure and mean arterial blood pressure 
were monitored by noninvasive automated oscillatory method and Heart 
rate  was  measured  by  ECG,  before  spinal  and  immediately  after  spinal 
anaesthesia.
Similarly during intraoperative   period readings were taken at  the 
interval  of 3minutes upto first 15 minutes, then every 5 minutes till 30th 
minute,  every  10  minutes  till  60th minute  and  every  15minutes  till  120 
minutes. All these readings were recorded in the master chart.
Other parameters such as SPO2 ,urine output, were also monitored. 
Blood loss was assessed.
Hypotension was defined as decrease in systolic BP of more than 20% 
of Baseline value. Hypotension was treated with IV fluids and inj.Ephedrine 
IV boluses of 6mg increments. Bradycardia was defined as heart rate less 
than 60/min and treated with inj. Atropine 0.3 mg increments.
The patients were observed in the recovery room & Blood pressure 
and other vital parameters were monitored every 30 minutes thereafter till 
the complete regression of the sensory & motor blockade
The following parameters  were observed post  operatively in  the post  op 
ward. Heart rate,Resp Rate,Oxygen Saturation,Blood Pressure
1. Urine Output 
2. Side effects like dry mouth, headache, palpitations, urinary 
retention,  anxiety  ,restlessness,  tremor,  nausea  and 
vomiting. 
OBSERVATIONS AND RESULTS
Table 1
Physical Parameters 
S.N
o
Physical 
Parameter
Control gp
Ephedrine 
group 
Pvalu
e 
Significance
  Mean SD Mean SD   
1 Age (Yrs) 37.96
7.9
3 38.84 8.53 0.498 Not. signifi
2 Height (cm) 166.7
3.1
8 166.3 2.93 0.323 Not. signifi
3 Weight (Kg) 58.52
4.1
9 58.78 4.11 0.632 Not. signifi
Table 2
Mean Systolic BP. Baseline
S.No Group No of Cases Mean SD Pvalue Significance
1 Control 50 119.06
7.1
8
2 Ephedrine 50 119.38 9.3
0.146 Not Signt
Table 3
Mean Diastolic BP. Baseline
S.No Group No of Cases Mean SD Pvalue Significance
1 Control 50 75.56
5.5
0
2 Ephedrine 50 76.72
4.8
2
0.542 Not Signt
Table 4
Mean of Mean Arterial Pressure Baseline 
S.No Group No of Cases Mean SD Pvalue Significance
1 Control 50 90.76
6.3
3
2 Ephedrine 50 90.74
5.4
6
0.653 Not Signt
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Table 5
Mean Heart rate Baseline 
S.No Group No of Cases Mean SD Pvalue Significance
1 Control 50 80.98
7.3
0
2 Ephedrine 50 78.94
7.7
9
0.210 Not Signt
Table 6
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DISCUSSION
Hypotension is one of the most common complications in patients 
undergoing spinal anaesthesia which cam compromise the perfusion of vital 
organs like Heart, brain & kidneys and can cause irreversible insult to these 
organs. Various methods have been employed to prevent this detrimental 
complication out of which prophylactic use of Ephedrine was found to be 
most effective. This correlates with the study done by Gajraj  NM  12 et al 
which concludes prophylactic ephedrine infusion was more effective than 
crystalloid preloading in prevention of spinal hypotension.
Various  studies  as  discussed  in  review  of  literature  have  used 
prophylactic ephedrine in various routes such as IM, IV bolus, IV infusion 
and Oral route as prophylaxis for spinal hypotension.
Our study was done to show the efficacy of oral ephedrine Tablets in 
preventing spinal hypotension. If found to be effective it could be one of the 
simplest  methods  of  preventing  this  lethal  complication  of  spinal 
anaesthesia.
Ephedrine is one of the most commonly used drugs in the prevention 
& treatment of spinal hypotension. It stimulates both ά and β receptors and 
releases nor epinephrine from neuronal strores. It is also orally effective as 
its oral  bioavailability is 85%. Its onset of action is 30 – 45 minute given 
orally and duration of action is 3 to 5 hrs. This substantiates the selection of 
our study  .
100 patients of ASA class I men undergoing various lower Abdominal 
& scrotal surgeries were chosen between the age group of 25-55 yrs and 
were randomly allocated into two groups of 50 each. Group E (Ephedrine 
gp)  patients  received  30mg  of  oral  ephedrine  30min  prior  to  spinal 
anaesthesia with sips of water. Group C (Control gp) patients received no 
tablets.  Preloading with 10ml/kg of  Ringer lactate  was  done in both the 
groups over the period of 15 min after which spinal anaesthesia was given.
The dosage of ephedrine and the onset of action were supported by 
the textbook description and previous studies done by kafle  7 et al, fusun 
eroglu  8 et al subbiah  et al and PF  kotur  et al.They all concluded that 
oral  ephedrine  prophylaxis  significantly  reduces  the  incidence  of  spinal 
induced hypotension. If 3.2 to  3.5 ml of 0.5% (H) Bupivacaine was used for 
spinal anaesthesia. It was given in L3 L4 space  with patient  in Right lateral 
position. Immediately after spinal the patient was turned to supine position 
with 100 head up tilt  till  the fixation of drug and the level of block was 
optimized between T6 – T8. 
Monitoring  of  the  patients  was  done  from  administration  of 
ephedrine to the end of surgery and there after in the recovery room and 
postoperative  ward till complete regression of spinal anaesthesia.
Hemodynamic  parameters  such  as  systolic,  diastolic,  mean  arterial 
pressure and Heart rate were measured at baseline, prespinal, post spinal, 
3minutes  interval    upto 15minutes,  5minutes  interval  upto 30th minute, 
10minutes  interval  till  the  60th minute  15  minutes  interval  upto  120th 
minutes and recorded in the master chart.
Statistical analysis was done using students T test and chi square test 
to compare  the variables in both the groups.
Physical parameters such as age, height and weight in both groups 
were compared  and it was found that  ‘P’ value was not significant which 
states  that  patients  in  both the groups were similar  in terms of  physical 
parameters.
Baseline systolic, diastolic, mean arterial pressures in both the groups 
were analysed and found that P values were not significant which states 
that  patients  in  both  the  groups  were  similar  in  terms  of  baseline 
hemodynanmic parameters.
Hypotension was defined as  fall  in systolic BP,  more than 20% of 
baseline value, and was treated with inj. Ehedrine 6mg iv in increments till 
it  reached  within  20% of  baseline  value.  Heart  rate  less  than  60/min  s 
treated with inj atropine 0.3mg increments.
Kafle  7 et al have taken fall in SBP more than 20% of baseline value 
as significant hypotension in their study.
Fusun  eroglu  8 et al also had taken fall in SBP more than 20% of 
baseline value or less than 100mm Hg as significant hypotension in their 
study.
Rout  CC  13 et al took < 80% of Baseline SBP or < 100 mmHg from 
baseline as hypotension in their study of evaluation of crystalloid preload in 
the prevention of spinal hypotension.
In our study fall in Systolic BP more than 20% of baseline value was 
taken as hypotension. We found that 19 patients in the control group & one 
patient in ephedrine gp developed hypotension (ie  SBP falling < 80% of 
baseline  value).  Statistical  analysis  was  carried  out  and  found  that  the 
incidence  of  hypotension  is  38%  in  the  control  group  and  2%  in  the 
Ephedrine  group   (P  value  =  00001  ie.  <  0.05)  P  value  was  significant 
showing  that  incidence  of  hypotension  due  to  spinal  anaesthesia  is 
negligible in ephedrine group.
Kafle 7 et al found that incidence of hypotension in ephedrine group 
was  less  (55%)  Compared  to  control  group  (83%)  (P  value  0.01)  which 
correlates our study.
Fusun  eroglu  8 et  al  in  their  study  found  that  the  incidence  of 
hypotension is less in ephedrine group (23.33%) than control group( 50 %) p 
value was 0.003 which is significant and this substantiates our study.
Subbiah et al found out in their study that incidence of hypotension 
is less in the ephedrine group compared to control group.
Kotur  PF et al also found that incidence of hypotension is  nil  in 
ephedrine group (0%) compared to control group (22%).
All  those  studies  & various  other  studies  mentioned  in  review of 
literature using intramuscular, intravenous bolus or infusion ephedrine have 
proved that incidence of hypotension  is  less in  ephedrine group which 
support our study result.
In our study we found that none of the patients in the ephedrine 
group showed reactive hypertension or tachycardia. They didn’t have any 
side effects such as palpitation ,dry mouth, restlessness, tremor, nausea and 
vomiting during intraoperative period or the post operative period.
Kafle  7 et al and various other studies have shown that no adverse 
effects  were  observed  in  the  ephedrine  group  in  30mg  doses  which 
correlates with our study.
SUMMARY 
In  our  study  100  ASA  class  I  men  scheduled  for  elective  lower 
abdominal  &  scrotal  surgeries  under  spinal  anaesthesia  were  randomly 
divided into 2 groups. Group I patients (n = 50) received tab. Ephedrine  30 
mg and Group II (control) patients did not  receive tab Ephedrine
We found out that Group I receiving Tab. Ephedrine 30mg had lower 
incidence of hypotension (2%) compared to Group II (Control) (38%) and 
did not report any side effects.
CONCLUSION
From our  study we conclude  that  oral  ephedrine  prophylaxis  is  a 
simple,  easy,  economical  .  effective  and reliable  method in reducing the 
incidence  of  hypotension  following  subarachnoid  block  in  patients 
undergoing  elective  lower  abdominal  and  scrotal  surgeries  and  does  not 
have any adverse effects.
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PROFORMA
One year randomized study of comparison of prophylactic Oral ephedrine 
and control (without ephedrine) in reducing  the incidence of hypotension after 
subarachnoid  block in patients undergoing elective lower abdominal and scrotal 
surgeries .
Name IP No ASA Grade
Age; ward
Preoperative diagnosis
Surgery performed
Surgeon 
Anaesthesiologist 
Physical examination 
General examination 
Build pallor cyanosis
Weight icterus clubbing
Pedal ederna                              lymphadenopathy 
Vital parameters
Pulse rate
Blood pressure 
Respiratory rate
 Systems examination
(i) cardiovascular system
(ii) Respiratory system
(iii) Central nervous system
(iv) Gastro intestinal system
(v) Renal system
Investigations
Complete blood count
Urine routine examination
Random Blood sugar
Blood urea
Serum creatinine 
Premedication
Tab. Ranitidine 150 mg
Tab. Diazepam 10 mg              Night befoe surgery for Both groups
Group E
Tab.  Ephedrine 30mg. with sips of water 30 min before subarachniod  block.
Group P.
None
Preoperative Pulse rate
Blood pressure
Anaesthesia
Procedure : Rubarachnoid block
Posture : Right lateral
Site : L3 L4 subarachnoid space
Drug : Inj Bupivacame
Concentration : 0.5% Heavy
Dose : 3.2 to 3.5 ml
Level of Anaesthesia
Intra operative period
Monitoring 
S.no    Parameter    Baseline    Prespinal     Post spinal  3,6,9,12,15,20 
1.    Pulse rate
2.          Systolic Blood pressure
3.          Diastolic Blood pressure
4. SPO2
25 30 40 50 60 75 90 120 min 
Pulse rate
1. Systor Blood pressure
2. Dlastolic Blood pressure
3. SPO2
                                         
IV fluids Blood Drugs
Blood loss
                            Urine output
